Barr challenges Novartis over Ritalin patents Heritage launches its formulation of the generic hydrochlorothiazide Perrigo sees impressive sales, expects more in the near future Daiichi Sankyo predicts increased R&D costs will cut into sales profits FDA issues not approvable letter for gepirone AVI gets fast-track status from FDA for DMD drug candidate Tim Russert to speak at NACDS Foundation dinner FDA seizes over $300,000 of product from General Theraputics Senate passes revised SCHIP despite expectations of a second veto Court grants GSK's motion against U.S. patent office First Previous 2638 2639 2640 2641 2642 Next Last